:

Hayrettin Tonbul1,2,3, Priyanka Arunachalam1,4, Md Adnan1,2

  • 1Utah Center for Nanomedicine, University of Utah, Salt Lake City, Utah 84112, United States.

Molecular pharmaceutics
|February 17, 2026
PubMed
概括

这项研究探讨了二氧化纳米粒子特性如何影响巨细胞安全性和免疫反应. 虽然通常是安全的,但某些PEGylated和棒状纳米颗粒显示出显著的免疫激活.